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Myxoinflammatory fibroblastic sarcoma (MIFS) is a recently defined rare tumor. It is mainly found in the upper and 
lower extremities of adults. Due to its high local recurrence rate and low metastatic rate, it is classified as a low 
grade-malignancy. Accurate diagnosis and early, wide excision are important for prognosis. Herein, we report a 
case of MIFS in a 35-year-old male patient that presented in an unusual location, the left chest wall. To our 
knowledge, this is the first reported case of MIFS in Korea and the second case to be reported within the global 
scientific literature involving the chest wall.
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CASE REPORT
A  35-year-old  man  visited  our  hospital  presenting  with  a 
palpable  mass  on  his  left  lateral  chest  wall,  which  was  mov-
able, rubbery, and non-tender. A gun biopsy assisted by ultra-
sonography  was  performed,  but  failed  to  confirm  a  specific 
diagnosis; therefore, we performed a local excision. The mass 
was  3×2×1  cm,  non-adhesive,  round,  and  pink;  the  cut  sec-
tions  evidenced  well-demarcated,  gray-white  gelatinous  mass-
es.  A  microscopic  examination  revealed  a  tumor  in  the  sub-
cutaneous  tissues  without  invasion  to  the  adjacent  structures 
(Fig.  1).  The  specimen  exhibited  a  mixture  of  myxoid,  hya-
line,  and  inflammatory  zones  (Fig.  2).  Scattered  and  enlarged 
tumor cells, each with a large eosinophilic nucleus resembling 
a  virocyte,  were  observed,  consistent  with  a  diagnosis  of 
m y x o i n f l a m m a t o r y  f i b r o b l a s t i c  s a r c o m a  ( M I F S )  ( F i g .  3 A ,  B ) .  
An  immunohistochemical  study  revealed  that  the  tumor  cells 
had  a  strong  positivity  for  vimentin  and  focal  positivity  for 
CD34  and  CD68,  confirming  the  diagnosis  of  MIFS.
A  microscopic  histological  analysis  of  the  specimen  re-
vealed  that  the  mass  was  abutting  to  the  resection  margin  in 
a series of multifocal areas. Thus, an additional wide excision 
was advised for an adequate tumor-free margin. On combined 
positron emission tomography and computed tomography, flu-
oro-2-deoxy-D-glucose  uptake  was  increased  at  the  left  chest 
wall,  probably  due  to  a  previous  procedure;  multiple  nodules 
were also observed in the right lung, suggesting possible lung 
metastasis.
After  administering  general  anesthesia  and  single-lung  ven-
tilation,  a  wedge  resection  of  the  right  upper  lung,  including 
the  nodules,  was  performed  under  video-assisted  thoraco-
scopic  surgery  conditions.  The  frozen  sectional  diagnosis  of 
the lung nodules confirmed a benign pneumocyte hyperplasia. 
Subsequently,  a  wide  left  chest  wall  excision  was  performed, 
including  partial  resections  of  the  5th,  6th,  and  7th  ribs.  The 
tumor free margin of the subcutaneous and muscle layers was Kyoung Shik Narm, et al
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Fig. 1. A lower-power view of the inflammatory myxohyaline tu-
mor illustrating a mixture of myxoid, hyaline, and inflammatory
zones (H&E, ×12).
Fig. 2. An admixture of myxoid, hyaline, and inflammatory zones 
in an inflammatory myxohyaline tumor. Note the transition between 
myxoid and hyaline zones (H&E, ×100).
Fig. 3. (A) A higher-magnification view of cells with smudgy nuclei in a myxoid zone of an inflammatory myxohyaline tumor (H&E, ×200).
(B) An enlarged tumor cell with a large eosinophilic nucleus resembling a virocyte in an inflammatory myxohyaline tumor (H&E, ×400).
4  cm,  and  the  skin  margin  was  2  cm.  After  the  procedure, 
there  was  no  gross  evi d e n c e  o f  a  r e s i d u a l  t u m o r .  T h e  c h e s t  
wall was reconstructed with polypropylene mesh (Marlex, CR 
Bard Inc., Billerica, MA, USA) and bone cement. The patient 
was  discharged  on  postoperative  day  10.
DISCUSSION
MIFS, or acral MIFS, is a low-grade, malignant tumor that 
has only recently been defined pathologically. About 200 cas-
es have been reported since it was first described in 1998 by 
Montgomery  et  al.  [1].
In  80%  of  cases,  the  lesion  involves  the  subcutaneous  tis-
sues of the hands or feet [2], but it can be also be found on 
the  elbows,  thighs,  or  shoulders;  thus  the  term  “acral”  was 
dropped in the  2002 World Health Organization  classification 
[3].
Clinically,  MIFS  usually  presents  as  a  slow-growing,  soli-
tary,  and  painless  mass  that  can  sometimes  infiltrate  ex-
tensively  into  the  surrounding  soft  tissues.  Grossly,  it  is  usu-Myxoinflammatory Fibroblastic Sarcoma
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ally visible as an ill-defined, multinodular mass, with myxoid 
areas,  within  the  subcutaneous  tissue,  and  has  an  irregular 
border  and  invasive  margin  [1,4].  Necrosis  or  hemorrhage 
may  also  occur.  The  tumors  are  1−8  cm  in  size  and  dis-
charge  a  clear,  jelly-like  substance  when  compressed  [4].
The simple X-ray imaging of the affected area did not pro-
vide any specific  findings.  A magnetic  resonance  imaging  al-
so  provided  no  pathognomonic  patterns  because  of  the  mass’ 
varied  histological  composition;  however,  the  images  did  ex-
hibit low signal intensity on the T1-weighted image and high 
signal  intensity  on  the  T2-weighed  image.
Histologically,  the  mass  was  composed  of  dense,  mixed 
acute  and  chronic  inflammatory  cells,  and  the  hypocellular 
area  was  composed  of  hyaline  and  myxoid  zones. 
Characteristic ganglion-like, lipoblast-like, and polygonal spin-
dle  cells  that  contained  bizarrely  shaped  nuclei  and  in-
clusion-like nucleoli were present in an abundant eosinophilic 
cytoplasm. These cells were derived from the modified fibro-
blast  cells  and  chronic  inflammatory  cells.  A  mitotic  division 
was  generally  rare,  and  necrosis  was  often  evident.  Upon  the 
immunohistochemical  study,  vimentin  was  always  positive, 
CD68  and  CD34  exhibited  variable  positivity,  and  HMB45 
and  CD45  were  always  negative  [4]. 
The  differential  diagnosis can be broad and  varied depend-
ing  on  whether  the  inflammatory,  myxoid,  or  bizarre  atypical 
component  predominates  within  the  lesion.  Tenosynovitis, 
ganglion cyst, and myxoma (for the inflammatory and benign 
entities),  and  myxoid  malignant  fibrous  histiocytoma,  myxoid 
liposarcoma,  and  epithelioid  sarcoma  (for  the  malignant  tu-
mors)  are  the  main  components  of  the  histopathological  dif-
ferential  diagnosis  of  a  giant  cell  tumor  in  the  tendon  sheath 
or  of  a  myxoid  origin  [2,5].  Because  of  the  difficulty  of  an 
accurate  diagnosis  from  the  lesion’s  clinical  presentation  or 
radiological  characteristics, the diagnosis is often delayed and 
a  surgical  excision  is  more  likely  to  be  suboptimal. 
The local recurrence rate of the tumor is high (range, 22% 
to  67%)  when  a  local  excision  alone  has  been  performed, 
usually  being  reported  between  3  months  and  5  years  post-
operatively  [4].  The  distant  metastasis  rate  is  low  (6.5%); 
however,  cases  have  reported  metastasis  to  the  lung,  neck, 
and  skull  [6,7].  One  tumor-related  death  has  been  reported 
[6].
Although  the  treatment  process  has  not  been  well-defined, 
a  complete  excision  with  clear  margins  is  recommended. 
Postoperative  radiotherapy  may  be  a  good  additional  therapy 
for  patients  who  have  a  large  tumor  or  a  positive  resection 
m a r g i n  [ 2 , 8 ] .  S o m e  p apers  also  report  chemotherapy  as  an 
option  [4].
There  has  only  been  one  other  reported  case  of  MIFS  in-
volving  the  chest  wall.  Premalata  et  al.  [5]  reported  upon  a 
MIFS of the upper back, over the scapula. They performed a 
wide  excision  of  the  tumor,  without  rib  resection,  and  re-
ported no recurrence within 10 months after surgery. We per-
fo rm ed a w ider  lo cal ex cision  w ith a tum or  fr ee mar gin o f 4  
cm, including an adjacent rib resection and the reconstruction 
of the chest wall, in accordance with the guidelines for a ma-
lignant  tumor  of  the  chest  wall.
In summary, MIFS is a very rare tumor that predominantly 
affects  the  distal  extremities.  It  has  not  been  previously  de-
scribed  in  the  Korean  literature.  We  report  the  first  case  of 
MIFS  in  Korea,  and  the  second  such  tumor  to  be  described 
i n  t h e  c h e s t  w a l l .  T h e  p a t i e n t  u n d e r w e n t  a  w i d e  l o c a l  e x -
cision  and  a  chest  wall  reconstruction.
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